Company Expects Q2 2026 Adjusted EBITDA Margin of 6.7%-7.2%
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 3 days ago
0mins
Should l Buy AMN?
Sees Q2 adjusted EBITDA margin 6.7%-7.2%. "Revenue in the second quarter of 2026 is expected to be 4-6% lower than the prior year, or down 3-5% excluding labor disruption revenue of approximately $10 million this quarter compared with $16 million in the second quarter of 2025. Nurse and Allied Solutions segment revenue is expected to be down 0-2% year over year. Physician and Leadership Solutions segment revenue is expected to be down 6-8% year over year. Technology and Workforce Solutions segment revenue is projected to be down 14-16% year over year, including a (4%) effect from the divestiture of Smart Square at the beginning of third quarter 2025," the company stated.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AMN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AMN
Wall Street analysts forecast AMN stock price to fall
5 Analyst Rating
3 Buy
2 Hold
0 Sell
Moderate Buy
Current: 28.970
Low
22.00
Averages
23.50
High
25.00
Current: 28.970
Low
22.00
Averages
23.50
High
25.00
About AMN
AMN Healthcare Services, Inc. is a provider of total talent solutions for healthcare organizations across the United States. The Company provides access to a comprehensive network of quality healthcare professionals through its recruitment strategies and breadth of career opportunities. Its segments include nurse and allied solutions, physician and leadership solutions, and technology and workforce solutions. The nurse and allied solutions segment include its travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, and allied staffing businesses. The physician and leadership solutions segment includes its locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement businesses. The technology and workforce solutions segment includes the Company’s language services, vendor management systems (VMS), workforce optimization, and outsourced solutions businesses.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
AMN (AMN) Q1 2026 Earnings Call Transcript
See More
AMN Healthcare Reports Strong Q1 Earnings Beat
- Earnings Beat: AMN Healthcare's Q1 non-GAAP EPS of $2.10 exceeded expectations by $0.48, demonstrating robust performance in the healthcare sector and reinforcing its market position.
- Significant Revenue Growth: The company reported Q1 revenue of $1.38 billion, a staggering 100.1% increase year-over-year, surpassing market expectations by $150 million, reflecting strong demand in the labor market and effective business expansion strategies.
- Strong Cash Flow: As of March 31, 2026, AMN had cash and cash equivalents totaling $561 million, with Q1 operating cash flow at $562 million, indicating solid financial management and sustained profitability.
- Positive Outlook: The company provided Q2 2026 revenue guidance of $620 to $635 million, with gross margin expectations of 28.0%-28.5%, showcasing management's confidence in future growth and offering clear growth expectations for investors.
See More
AMN Healthcare Schedules Q1 2026 Earnings Call
- Earnings Call Scheduled: AMN Healthcare has scheduled a conference call for May 7, 2026, at 5:00 PM ET to discuss its Q1 2026 financial results and Q2 outlook, reflecting the company's commitment to transparency and investor communication.
- Earnings Release Timing: The company plans to issue its earnings news release on the same day at approximately 4:15 PM, allowing investors to access critical information promptly for informed decision-making.
- Webcast Availability: The call will be accessible via a live webcast, which can be found on the company's investor relations website, enhancing information accessibility and demonstrating the company's focus on investor engagement.
- Healthcare Leadership Position: In 2025, AMN Healthcare served over 13 million patients across more than 2,300 healthcare systems, underscoring its leadership and innovation in the healthcare sector, thereby solidifying its competitive advantage in the market.
See More
Marsh's Acquisition of AltamarCAM Boosts Stock Price
- Stock Price Recovery: Marsh (MRSH) shares rose 3.3% in the last trading session to close at $176.48, with notable trading volume exceeding typical levels, despite a 4.5% decline over the past four weeks.
- Asset Acquisition Value: Marsh's Mercer unit agreed to acquire AltamarCAM, adding €20 billion in assets under management, positioning Madrid as a key hub and strengthening its presence in Europe and Latin America.
- Positive Earnings Outlook: The upcoming quarterly earnings report is expected to show an EPS of $3.22, reflecting a year-over-year increase of 5.2%, with revenues projected at $7.39 billion, up 4.6%, indicating strong future growth potential.
- Earnings Estimate Revision: Despite positive earnings expectations, the consensus EPS estimate has been revised 0.7% lower over the last 30 days, which typically does not correlate with stock price appreciation, necessitating close monitoring of MRSH's future performance.
See More
Healthcare Executives See Confidence Gap Amid Industry Challenges
- Widening Confidence Gap: Nearly three-quarters of healthcare executives believe their organizations will be as strong or stronger in 2026, yet over half expect the overall industry to face a worse year, indicating a significant divergence in confidence that could impact investment and strategic decisions.
- Surge in AI Leadership Demand: With 63% of executives citing the need for a clear AI strategy, 48% emphasizing clinician and staff engagement for adoption, and 41% focusing on data infrastructure investment, the rising importance of AI in leadership is poised to transform healthcare delivery.
- Cooling Retention Risks: While 35% of leaders are considering leaving within a year, the report notes a reduced urgency to move compared to previous years, potentially giving organizations more time to enhance employee retention strategies.
- Limited Advancement Opportunities: Only 21% of respondents feel they are on a promotion track, while 26% believe they must leave their employer to advance, highlighting a significant issue with limited internal promotion opportunities that may lead to talent attrition.
See More
AMN Healthcare Reports Strong Q4 2025 Earnings with Labor Disruption Revenue Surge
- Strong Financial Performance: AMN Healthcare reported Q4 2025 revenue of $748 million, a 2% year-over-year increase and $18 million above guidance, indicating robust performance in labor disruption revenue that is expected to drive future growth.
- EBITDA and Net Loss: While adjusted EBITDA was $54 million, down 27% year-over-year, the net loss improved significantly from $188 million last year to $8 million, reflecting substantial progress in cost control and operational optimization.
- Optimistic Outlook: The company projects Q1 2026 revenue between $1.225 billion and $1.24 billion, with approximately $600 million from labor disruption support, demonstrating confidence in future market demand, although gross margin is expected to be impacted by 300 basis points.
- Accelerated Technology Investment: Management emphasized investments in AI technology to enhance efficiency in non-clinical patient interactions, indicating strategic decisions to adapt to market changes and improve service quality, aiming for sustainable organic revenue growth of 4% to 6% in the future.
See More
AMN (AMN) Q1 2026 Earnings Call Transcript
See More
AMN Healthcare Reports Strong Q1 Earnings Beat
- Earnings Beat: AMN Healthcare's Q1 non-GAAP EPS of $2.10 exceeded expectations by $0.48, demonstrating robust performance in the healthcare sector and reinforcing its market position.
- Significant Revenue Growth: The company reported Q1 revenue of $1.38 billion, a staggering 100.1% increase year-over-year, surpassing market expectations by $150 million, reflecting strong demand in the labor market and effective business expansion strategies.
- Strong Cash Flow: As of March 31, 2026, AMN had cash and cash equivalents totaling $561 million, with Q1 operating cash flow at $562 million, indicating solid financial management and sustained profitability.
- Positive Outlook: The company provided Q2 2026 revenue guidance of $620 to $635 million, with gross margin expectations of 28.0%-28.5%, showcasing management's confidence in future growth and offering clear growth expectations for investors.
See More
AMN Healthcare Schedules Q1 2026 Earnings Call
- Earnings Call Scheduled: AMN Healthcare has scheduled a conference call for May 7, 2026, at 5:00 PM ET to discuss its Q1 2026 financial results and Q2 outlook, reflecting the company's commitment to transparency and investor communication.
- Earnings Release Timing: The company plans to issue its earnings news release on the same day at approximately 4:15 PM, allowing investors to access critical information promptly for informed decision-making.
- Webcast Availability: The call will be accessible via a live webcast, which can be found on the company's investor relations website, enhancing information accessibility and demonstrating the company's focus on investor engagement.
- Healthcare Leadership Position: In 2025, AMN Healthcare served over 13 million patients across more than 2,300 healthcare systems, underscoring its leadership and innovation in the healthcare sector, thereby solidifying its competitive advantage in the market.
See More
Marsh's Acquisition of AltamarCAM Boosts Stock Price
- Stock Price Recovery: Marsh (MRSH) shares rose 3.3% in the last trading session to close at $176.48, with notable trading volume exceeding typical levels, despite a 4.5% decline over the past four weeks.
- Asset Acquisition Value: Marsh's Mercer unit agreed to acquire AltamarCAM, adding €20 billion in assets under management, positioning Madrid as a key hub and strengthening its presence in Europe and Latin America.
- Positive Earnings Outlook: The upcoming quarterly earnings report is expected to show an EPS of $3.22, reflecting a year-over-year increase of 5.2%, with revenues projected at $7.39 billion, up 4.6%, indicating strong future growth potential.
- Earnings Estimate Revision: Despite positive earnings expectations, the consensus EPS estimate has been revised 0.7% lower over the last 30 days, which typically does not correlate with stock price appreciation, necessitating close monitoring of MRSH's future performance.
See More
Healthcare Executives See Confidence Gap Amid Industry Challenges
- Widening Confidence Gap: Nearly three-quarters of healthcare executives believe their organizations will be as strong or stronger in 2026, yet over half expect the overall industry to face a worse year, indicating a significant divergence in confidence that could impact investment and strategic decisions.
- Surge in AI Leadership Demand: With 63% of executives citing the need for a clear AI strategy, 48% emphasizing clinician and staff engagement for adoption, and 41% focusing on data infrastructure investment, the rising importance of AI in leadership is poised to transform healthcare delivery.
- Cooling Retention Risks: While 35% of leaders are considering leaving within a year, the report notes a reduced urgency to move compared to previous years, potentially giving organizations more time to enhance employee retention strategies.
- Limited Advancement Opportunities: Only 21% of respondents feel they are on a promotion track, while 26% believe they must leave their employer to advance, highlighting a significant issue with limited internal promotion opportunities that may lead to talent attrition.
See More
AMN Healthcare Reports Strong Q4 2025 Earnings with Labor Disruption Revenue Surge
- Strong Financial Performance: AMN Healthcare reported Q4 2025 revenue of $748 million, a 2% year-over-year increase and $18 million above guidance, indicating robust performance in labor disruption revenue that is expected to drive future growth.
- EBITDA and Net Loss: While adjusted EBITDA was $54 million, down 27% year-over-year, the net loss improved significantly from $188 million last year to $8 million, reflecting substantial progress in cost control and operational optimization.
- Optimistic Outlook: The company projects Q1 2026 revenue between $1.225 billion and $1.24 billion, with approximately $600 million from labor disruption support, demonstrating confidence in future market demand, although gross margin is expected to be impacted by 300 basis points.
- Accelerated Technology Investment: Management emphasized investments in AI technology to enhance efficiency in non-clinical patient interactions, indicating strategic decisions to adapt to market changes and improve service quality, aiming for sustainable organic revenue growth of 4% to 6% in the future.
See More
